- Targeting the DNA Damage Response Machinery for Lung Cancer Treatment
Katharigatta N. Venugopala, 2022, Pharmaceuticals CrossRef - Clinical implications of aberrant PD-1 expression for acute leukemia prognosis
Yanjie Ruan et al, 2023, European Journal of Medical Research CrossRef - The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy
Lu Wen et al, 2021, Frontiers in Oncology CrossRef - Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines
Marika Saar et al, 2023, Pharmaceutics CrossRef